GlassScriptPhysician profile
Matthew David Truitte
NPI 1023631520
$799.69
in general payments reported to CMS, 2019-2025
10 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $175 · 2023: $234 · 2024: $161 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.18 |
| Education | $153.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $158.07 | 2024-2025 | |
| Medtronic, INC. | $153.00 | 2023 | |
| Abbott Laboratories | $122.23 | 2022-2024 | Jot Dx |
| Boston Scientific Corporation | $113.36 | 2022-2024 | Watchman Access System |
| Abiomed | $81.68 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.45 | 2023-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $30.39 | 2023-2024 | |
| Edwards Lifesciences Corporation | $25.39 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals International, Plc | $25.33 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $16.79 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Truitte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.